Psychedelic Patent Wars

Rick Doblin

FILE - Rick Doblin, the founder and director of the Multidisciplinary Association for Psychedelic Studies, or MAPS, stands for a portrait in Vista, Calif., on Aug. 15, 2018. On principle, the group’s pharmaceutical arm, has never patented its work. But as investment opportunities have multiplied, charitable donations have dried up. The group was recently forced to take on private investors to continue funding the drug company, which recently changed its name to Lykos Therapeutics. “We’re a victim of our own success,” said Doblin. “It’s heartbreaking because I had hoped to go the whole way with philanthropy, but I was unable to raise all the mega millions to do that.” (AP Photo/Gregory Bull, File) AUG 15 2018 PHOTO

▶제보는 카톡 okjebo